These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 15078255

  • 1. Nucleic acid testing in blood donations reactive to hepatitis C virus antibody, but with an extremely low viral load.
    Laperche S, Bouchardeau F, Maniez M, Béolet M, Elghouzzi MH, Lefrère JJ.
    Vox Sang; 2004 Apr; 86(3):198. PubMed ID: 15078255
    [No Abstract] [Full Text] [Related]

  • 2. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.
    Stramer SL, Glynn SA, Kleinman SH, Strong DM, Caglioti S, Wright DJ, Dodd RY, Busch MP, National Heart, Lung, and Blood Institute Nucleic Acid Test Study Group.
    N Engl J Med; 2004 Aug 19; 351(8):760-8. PubMed ID: 15317889
    [Abstract] [Full Text] [Related]

  • 3. Yield of hepatitis C virus nucleic acid testing among antibody-reactive or confirmed-positive samples.
    Schmidt M, Weber M, Busch MP, Tobler LH, Phelps BH, Seifried E, Roth WK.
    Transfusion; 2005 Jun 19; 45(6):1040-2. PubMed ID: 15935008
    [No Abstract] [Full Text] [Related]

  • 4. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
    León P, López JA, Elola C, Domingo CJ, Echevarria JM.
    Vox Sang; 1996 Jun 19; 70(4):213-6. PubMed ID: 9123926
    [Abstract] [Full Text] [Related]

  • 5. Detection of hepatitis C virus and human immunodeficiency virus-1 antibody-negative donations: Canadian Blood Services' experience with nucleic acid testing.
    O'Brien SF, Fan W, Scalia V, Goldman M, Fearon MA, Vamvakas EC.
    Vox Sang; 2006 Apr 19; 90(3):204. PubMed ID: 16507022
    [No Abstract] [Full Text] [Related]

  • 6. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L, Chen PJ, Chen MH, Chak KF, Lin KS, Tsai SJ.
    Transfusion; 2008 Jun 19; 48(6):1198-206. PubMed ID: 18422856
    [Abstract] [Full Text] [Related]

  • 7. Prolonged hepatitis C virus seroconversion in a blood donor, detected by HCV antigen test in parallel with HCV RNA.
    Alvarez M, Planelles D, Vila E, Montoro J, Franco E.
    Vox Sang; 2004 May 19; 86(4):266-7. PubMed ID: 15144533
    [No Abstract] [Full Text] [Related]

  • 8. Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection.
    Busch MP, Glynn SA, Wright DJ, Hirschkorn D, Laycock ME, McAuley J, Tu Y, Giachetti C, Gallarda J, Heitman J, Kleinman SH, National Heart, Lung, Blood Institute Nucleic Acid Test Study Group*.
    Transfusion; 2005 Dec 19; 45(12):1853-63. PubMed ID: 16371038
    [Abstract] [Full Text] [Related]

  • 9. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing.
    Busch MP, Caglioti S, Robertson EF, McAuley JD, Tobler LH, Kamel H, Linnen JM, Shyamala V, Tomasulo P, Kleinman SH.
    N Engl J Med; 2005 Aug 04; 353(5):460-7. PubMed ID: 16079369
    [Abstract] [Full Text] [Related]

  • 10. First case of hepatitis C virus transmission by a red blood cell concentrate after introduction of nucleic acid amplification technique screening in Germany: a comparative study with various assays.
    Kretzschmar E, Chudy M, Nübling CM, Ross RS, Kruse F, Trobisch H.
    Vox Sang; 2007 May 04; 92(4):297-301. PubMed ID: 17456153
    [Abstract] [Full Text] [Related]

  • 11. An easy dipstick assay for anti-core antibodies to screen blood donors for hepatitis C virus viremia.
    Mulyanto, Suwignyo S, Tsauri S, Itoh K, Mizui M, Tsuda F, Okamoto H, Yoshizawa H, Mishiro S.
    Vox Sang; 1996 May 04; 70(4):229-31. PubMed ID: 9123929
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Planning and significance of tests to confrim the presence of anti-hepatitis-C antibodies in blood donors. Spanish Study Group for Blood Donors at Risk].
    León P, Echevarría JM.
    Sangre (Barc); 1999 Oct 04; 44(5):309-14. PubMed ID: 10618905
    [No Abstract] [Full Text] [Related]

  • 14. Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.
    Galel SA, Strong DM, Tegtmeier GE, Holland PV, Kuramoto IK, Kemper M, Pietrelli L, Gallarda J.
    Transfusion; 2002 Nov 04; 42(11):1507-13. PubMed ID: 12421226
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Implementation of an 'in-house' PCR assay validated for the detection of hepatitis C virus RNA.
    Lombardi GR, Oviedo A, Freytes F, Zarzur J, Guglielmone H, Vitali MS.
    Transfus Med; 2008 Oct 04; 18(5):317-9. PubMed ID: 18937742
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Detection of the nucleic acids of hepatitis B and C viruses and human immunodeficiency virus for the biological screening of blood donations. Viral Hepatitis and Retrovirus Working Groups and Subgroup for Molecular Biology Applied to Transfusion Virology of the French Blood Transfusion Society].
    Laperche S.
    Transfus Clin Biol; 1998 Apr 04; 5(2):139-46. PubMed ID: 9618839
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.